Skip to main content
Log in

Unilateral adrenalectomy improves insulin resistance and polycystic ovaries in a middle-aged woman with virilizing adrenocortical adenoma complicated with Cushing’s syndrome

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A benign virilizing adrenal adenoma is rare among adrenal neoplasms in middle-aged women. A 39-yr-old Japanese woman who presented with hirsutism, obesity, diabetes mellitus and hypertension was admitted. Plasma concentrations of testosterone and DHEAS were high. While the basal level of plasma ACTH was suppressed, serum cortisol level was high and its circadian rhythm was absent. Serum cortisol level was not suppressed with the low- and high-dose overnight dexamethasone suppression test. Abdominal computed tomography showed a left adrenal tumor, and an adrenocortical scintigraphy revealed uptake of the tracer on the left side. Polycystic ovaries were also found and bone mineral density revealed osteoporosis. Histopathological features of resected adrenal tumor were consistent with those of adrenocortical adenoma. Immunoreactivity of all the steroidogenic enzymes was apparent in the tumor cells and particularly dehydroepiandrosterone sulfotransferase (DHEA-ST) immunoreactivity was markedly expressed. Cortical atrophy and reduced expression of DHEA-ST were detected in the cortex of the adjacent non-neoplastic adrenal gland. Plasma testosterone, DHEAS and cortisol levels returned to normal after surgery, concomitantly with the disappearance of polycystic ovaries. This is a very rare case of virilizing adrenocortical adenoma complicated with Cushing’s syndrome (CS).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fukushima A, Okada Y, Tanikawa T, et al. Virilizing adrenocortical adenoma with Cushing’s syndrome, thyroid papillary carcinoma and hypergastrinemia in a middle-aged woman. Endocr J 2003, 50: 179–87.

    Article  PubMed  Google Scholar 

  2. Derksen J, Nagesser SK, Meinders AE, et al. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 1994, 331: 968–73.

    Article  CAS  PubMed  Google Scholar 

  3. Del Gaudio AD, Del Gaudio GA. Virilizing adrenocortical tumors in adult women. Report of 10 patients, 2 of whom each had a tumor secreting only testosterone. Cancer 1993, 72: 1997–2003.

    Article  PubMed  Google Scholar 

  4. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984, 18: 163–9.

    Article  Google Scholar 

  5. Weiss LM, Mederios LJ, Vickery AL. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989, 13: 202–6.

    Article  CAS  PubMed  Google Scholar 

  6. Barbieri RL. Hyperandrogenic disorders. Clin Obstet Gynecol 1990, 33: 640–54.

    Article  CAS  PubMed  Google Scholar 

  7. Lipsett MB, Hertz R, Ross GT. Clinical and pathophysiologic aspects of adrenocortical carcinoma. Am J Med 1963, 35: 374.

    Article  CAS  PubMed  Google Scholar 

  8. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19: 41–7.

    Article  Google Scholar 

  9. Copeland PM. The incidentally discovered adrenal mass. Ann Intern Med 1983, 98: 940–5.

    Article  CAS  PubMed  Google Scholar 

  10. Sasano H, Sato F, Shizawa S, et al. Immunolocalization of dehydroepiandrosterone sulfotransferase in normal and pathologic human adrenal gland. Mod Pathol 1995, 8: 891–6.

    CAS  PubMed  Google Scholar 

  11. Morio H, Terano T, Yamamoto K, et al. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing’s syndrome and non-functional adrenal tumor. Endocr J 1996, 43: 387–96.

    Article  CAS  PubMed  Google Scholar 

  12. Sakai Y, Yanase T, Takayanagi R, et al. High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing’s syndrome associated with high secretion of adrenal androgens. J Clin Endocrinol Metab 1993, 76: 1286–90.

    CAS  PubMed  Google Scholar 

  13. Kaltsas GA, Isidori AM, Besser GM, et al. Secondary forms of polycystic ovary syndrome. Trends Endocrinol Metab 2004, 15: 204–10.

    Article  CAS  PubMed  Google Scholar 

  14. Futterweit W, Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 1986, 62: 16–21.

    Article  CAS  PubMed  Google Scholar 

  15. Kaltsas GA, Korbonits M, Isidori AM, et al. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing’s syndrome? Clin Endocrinol (Oxf) 2000, 53: 493–500.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Shimizu MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, A., Shimizu, C., Nagai, S. et al. Unilateral adrenalectomy improves insulin resistance and polycystic ovaries in a middle-aged woman with virilizing adrenocortical adenoma complicated with Cushing’s syndrome. J Endocrinol Invest 30, 65–69 (2007). https://doi.org/10.1007/BF03347398

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347398

Key-words

Navigation